Skip to main content

Find Clinical Trials

Home
Conditions
Uterine Diseases

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

3,042 public trials 693 recruiting studies

Refine in advanced search Browse all conditions

Uterine Diseases trial results

Completed

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

NCT00072176

Conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, +19 more
Locations: National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada

View Trial Details

Completed

AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)

NCT00122343

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

NCT02365935

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations: campus bio-medico of Rome Rome, Italy

View Trial Details

Completed

Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery

NCT00389974

Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, +15 more
Locations: National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada

View Trial Details

Completed

Observational Study of Dydrogesterone in Cycle Regularization

NCT02029144

Conditions: Abnormal Uterine Bleeding, Dydrogesterone, Female Urogenital Diseases, +13 more
Locations: Obstetrics and Gynecology Hospital of Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix

NCT02207660

Conditions: Cervical Cancer, Disease Attributes, Female Urogenital Diseases, +17 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Analysis of the Results of Treatment for Cervical Carcinoma in Limburg

NCT01059695

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Not specified

View Trial Details

Completed

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

NCT00092495

Conditions: Cervical Cancer, Communicable Diseases, Condylomata Acuminata, +29 more
Locations: Not specified

View Trial Details

Completed

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

NCT00499031

Conditions: Cervical Squamous Cell Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Colorado Gynecologic Oncology Group Aurora, Colorado, United States

The Hospital of Central Connecticut New Britain, Connecticut, United States

Decatur Memorial Hospital Decatur, Illinois, United States

Saint Vincent Hospital and Health Services Indianapolis, Indiana, United States

View all 22 locations

View Trial Details

Completed

Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

NCT00507741

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Not specified

View Trial Details